Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2002 Jul;110(7):655–664. doi: 10.1289/ehp.02110655

Apartment residents' and day care workers' exposures to tetrachloroethylene and deficits in visual contrast sensitivity.

Judith S Schreiber 1, H Kenneth Hudnell 1, Andrew M Geller 1, Dennis E House 1, Kenneth M Aldous 1, Michael S Force 1, Karyn Langguth 1, Elizabeth J Prohonic 1, Jean C Parker 1
PMCID: PMC1240911  PMID: 12117642

Abstract

Tetrachloroethylene (also called perchloroethylene, or perc), a volatile organic compound, has been the predominant solvent used by the dry-cleaning industry for many years. The U.S. Environmental Protection Agency (EPA) classified perc as a hazardous air pollutant because of its potential adverse impact on human health. Several occupational studies have indicated that chronic, airborne perc exposure adversely affects neurobehavioral functions in workers, particularly visual color discrimination and tasks dependent on rapid visual-information processing. A 1995 study by Altmann and colleagues extended these findings, indicating that environmental perc exposure at a mean level of 4,980 microg/m(3) (median=1,360 microg/m(3)) alters neurobehavioral functions in residents living near dry-cleaning facilities. Although the U.S. EPA has not yet set a reference concentration guideline level for environmental exposure to airborne perc, the New York State Department of Health set an air quality guideline of 100 microg/m(3). In the current residential study, we investigated the potential for perc exposure and neurologic effects, using a battery of visual-system function tests, among healthy members of six families living in two apartment buildings in New York City that contained dry-cleaning facilities on the ground floors. In addition, a day care investigation assessed the potential for perc exposure and effects among workers at a day care center located in the same one-story building as a dry-cleaning facility. Results from the residential study showed a mean exposure level of 778 microg/m(3) perc in indoor air for a mean of 5.8 years, and that perc levels in breath, blood, and urine were 1-2 orders of magnitude in excess of background values. Group-mean visual contrast sensitivity (VCS), a measure of the ability to detect visual patterns, was significantly reduced in the 17 exposed study participants relative to unexposed matched-control participants. The groups did not differ in visual acuity, suggesting that the VCS deficit was of neurologic origin. Healthy workers in the day care investigation were chronically exposed to airborne perc at a mean of 2,150 microg/m(3) for a mean of 4.0 years. Again, group-mean VCS, measured 6 weeks after exposure cessation, was significantly reduced in the nine exposed workers relative to matched controls, and the groups did not differ significantly in visual acuity. These results suggested that chronic, environmental exposure to airborne perc adversely affects neurobehavioral function in healthy individuals. Further research is needed to assess the susceptibility of the young and elderly to perc-induced effects, to determine whether persistent solvent-induced VCS deficits are a risk factor for the development of neurologic disease, and to identify the no observable adverse effect level for chronic, environmental, perc exposure in humans.

Full Text

The Full Text of this article is available as a PDF (573.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander K. R., Derlacki D. J., Fishman G. A. Contrast thresholds for letter identification in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1992 May;33(6):1846–1852. [PubMed] [Google Scholar]
  2. Alexander K. R., Derlacki D. J., Fishman G. A. Visual acuity vs letter contrast sensitivity in retinitis pigmentosa. Vision Res. 1995 May;35(10):1495–1499. doi: 10.1016/0042-6989(95)98729-s. [DOI] [PubMed] [Google Scholar]
  3. Altmann L., Neuhann H. F., Krämer U., Witten J., Jermann E. Neurobehavioral and neurophysiological outcome of chronic low-level tetrachloroethene exposure measured in neighborhoods of dry cleaning shops. Environ Res. 1995 May;69(2):83–89. doi: 10.1006/enrs.1995.1028. [DOI] [PubMed] [Google Scholar]
  4. Altmann L., Sveinsson K., Krämer U., Weishoff-Houben M., Turfeld M., Winneke G., Wiegand H. Visual functions in 6-year-old children in relation to lead and mercury levels. Neurotoxicol Teratol. 1998 Jan-Feb;20(1):9–17. doi: 10.1016/s0892-0362(97)00070-6. [DOI] [PubMed] [Google Scholar]
  5. Ashley D. L., Bonin M. A., Cardinali F. L., McCraw J. M., Holler J. S., Needham L. L., Patterson D. G., Jr Determining volatile organic compounds in human blood from a large sample population by using purge and trap gas chromatography/mass spectrometry. Anal Chem. 1992 May 1;64(9):1021–1029. doi: 10.1021/ac00033a011. [DOI] [PubMed] [Google Scholar]
  6. Ashley D. L., Bonin M. A., Cardinali F. L., McCraw J. M., Wooten J. V. Blood concentrations of volatile organic compounds in a nonoccupationally exposed US population and in groups with suspected exposure. Clin Chem. 1994 Jul;40(7 Pt 2):1401–1404. [PubMed] [Google Scholar]
  7. Atkin A., Wolkstein M., Bodis-Wollner I., Anders M., Kels B., Podos S. M. Interocular comparison of contrast sensitivities in glaucoma patients and suspects. Br J Ophthalmol. 1980 Nov;64(11):858–862. doi: 10.1136/bjo.64.11.858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bangstad H. J., Brinchmann-Hansen O., Hultgren S., Dahl-Jørgensen K., Hanssen K. F. Impaired contrast sensitivity in adolescents and young type 1 (insulin-dependent) diabetic patients with microalbuminuria. Acta Ophthalmol (Copenh) 1994 Dec;72(6):668–673. doi: 10.1111/j.1755-3768.1994.tb04677.x. [DOI] [PubMed] [Google Scholar]
  9. Bodis-Wollner I., Diamond S. P. The measurement of spatial contrast sensitivity in cases of blurred vision associated with cerebral lesions. Brain. 1976 Dec;99(4):695–710. doi: 10.1093/brain/99.4.695. [DOI] [PubMed] [Google Scholar]
  10. Bowman K. J. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol (Copenh) 1982 Dec;60(6):907–916. doi: 10.1111/j.1755-3768.1982.tb00621.x. [DOI] [PubMed] [Google Scholar]
  11. Broadwell D. K., Darcey D. J., Hudnell H. K., Otto D. A., Boyes W. K. Work-site clinical and neurobehavioral assessment of solvent-exposed microelectronics workers. Am J Ind Med. 1995 May;27(5):677–698. doi: 10.1002/ajim.4700270505. [DOI] [PubMed] [Google Scholar]
  12. Brugnone F., Perbellini L., Giuliari C., Cerpelloni M., Soave M. Blood and urine concentrations of chemical pollutants in the general population. Med Lav. 1994 Sep-Oct;85(5):370–389. [PubMed] [Google Scholar]
  13. Cai S. X., Huang M. Y., Chen Z., Liu Y. T., Jin C., Watanabe T., Nakatsuka H., Seiji K., Inoue O., Ikeda M. Subjective symptom increase among dry-cleaning workers exposed to tetrachloroethylene vapor. Ind Health. 1991;29(3):111–121. doi: 10.2486/indhealth.29.111. [DOI] [PubMed] [Google Scholar]
  14. Camisa J., Mylin L. H., Bodis-Wollner I. The effect of stimulus orientation on the visual evoked potential in multiple sclerosis. Ann Neurol. 1981 Dec;10(6):532–539. doi: 10.1002/ana.410100607. [DOI] [PubMed] [Google Scholar]
  15. Campagna D., Gobba F., Mergler D., Moreau T., Galassi C., Cavalleri A., Huel G. Color vision loss among styrene-exposed workers neurotoxicological threshold assessment. Neurotoxicology. 1996 Summer;17(2):367–373. [PubMed] [Google Scholar]
  16. Campagna D., Mergler D., Huel G., Bélanger S., Truchon G., Ostiguy C., Drolet D. Visual dysfunction among styrene-exposed workers. Scand J Work Environ Health. 1995 Oct;21(5):382–390. doi: 10.5271/sjweh.53. [DOI] [PubMed] [Google Scholar]
  17. Castillo L., Baldwin M., Sassine M. P., Mergler D. Cumulative exposure to styrene and visual functions. Am J Ind Med. 2001 Apr;39(4):351–360. doi: 10.1002/ajim.1025. [DOI] [PubMed] [Google Scholar]
  18. Cavalleri A., Belotti L., Gobba F., Luzzana G., Rosa P., Seghizzi P. Colour vision loss in workers exposed to elemental mercury vapour. Toxicol Lett. 1995 May;77(1-3):351–356. doi: 10.1016/0378-4274(95)03317-3. [DOI] [PubMed] [Google Scholar]
  19. Cavalleri A., Gobba F., Nicali E., Fiocchi V. Dose-related color vision impairment in toluene-exposed workers. Arch Environ Health. 2000 Nov-Dec;55(6):399–404. doi: 10.1080/00039890009604037. [DOI] [PubMed] [Google Scholar]
  20. Cavalleri A., Gobba F., Paltrinieri M., Fantuzzi G., Righi E., Aggazzotti G. Perchloroethylene exposure can induce colour vision loss. Neurosci Lett. 1994 Sep 26;179(1-2):162–166. doi: 10.1016/0304-3940(94)90959-8. [DOI] [PubMed] [Google Scholar]
  21. Chia S. E., Jeyaratnam J., Ong C. N., Ng T. P., Lee H. S. Impairment of color vision among workers exposed to low concentrations of styrene. Am J Ind Med. 1994 Oct;26(4):481–488. doi: 10.1002/ajim.4700260405. [DOI] [PubMed] [Google Scholar]
  22. Clayton C. A., Pellizzari E. D., Whitmore R. W., Perritt R. L., Quackenboss J. J. National Human Exposure Assessment Survey (NHEXAS): distributions and associations of lead, arsenic and volatile organic compounds in EPA region 5. J Expo Anal Environ Epidemiol. 1999 Sep-Oct;9(5):381–392. doi: 10.1038/sj.jea.7500055. [DOI] [PubMed] [Google Scholar]
  23. Cronin-Golomb A., Corkin S., Growdon J. H. Visual dysfunction predicts cognitive deficits in Alzheimer's disease. Optom Vis Sci. 1995 Mar;72(3):168–176. doi: 10.1097/00006324-199503000-00004. [DOI] [PubMed] [Google Scholar]
  24. Cronin-Golomb A., Corkin S., Rizzo J. F., Cohen J., Growdon J. H., Banks K. S. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol. 1991 Jan;29(1):41–52. doi: 10.1002/ana.410290110. [DOI] [PubMed] [Google Scholar]
  25. Dekant W., Berthold K., Vamvakas S., Henschler D., Anders M. W. Thioacylating intermediates as metabolites of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2,2-trichlorovinyl)-L-cysteine formed by cysteine conjugate beta-lyase. Chem Res Toxicol. 1988 May-Jun;1(3):175–178. doi: 10.1021/tx00003a008. [DOI] [PubMed] [Google Scholar]
  26. Dekant W., Martens G., Vamvakas S., Metzler M., Henschler D. Bioactivation of tetrachloroethylene. Role of glutathione S-transferase-catalyzed conjugation versus cytochrome P-450-dependent phospholipid alkylation. Drug Metab Dispos. 1987 Sep-Oct;15(5):702–709. [PubMed] [Google Scholar]
  27. Dekant W., Metzler M., Henschler D. Identification of S-1,2,2-trichlorovinyl-N-acetylcysteine as a urinary metabolite of tetrachloroethylene: bioactivation through glutathione conjugation as a possible explanation of its nephrocarcinogenicity. J Biochem Toxicol. 1986 Jun;1(2):57–72. doi: 10.1002/jbt.2570010206. [DOI] [PubMed] [Google Scholar]
  28. Donoghue A. M., Dryson E. W., Wynn-Williams G. Contrast sensitivity in organic-solvent-induced chronic toxic encephalopathy. J Occup Environ Med. 1995 Dec;37(12):1357–1363. doi: 10.1097/00043764-199512000-00005. [DOI] [PubMed] [Google Scholar]
  29. Echeverria D., White R. F., Sampaio C. A behavioral evaluation of PCE exposure in patients and dry cleaners: a possible relationship between clinical and preclinical effects. J Occup Environ Med. 1995 Jun;37(6):667–680. doi: 10.1097/00043764-199506000-00008. [DOI] [PubMed] [Google Scholar]
  30. Eguchi T., Kishi R., Harabuchi I., Yuasa J., Arata Y., Katakura Y., Miyake H. Impaired colour discrimination among workers exposed to styrene: relevance of a urinary metabolite. Occup Environ Med. 1995 Aug;52(8):534–538. doi: 10.1136/oem.52.8.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Fallas C., Fallas J., Maslard P., Dally S. Subclinical impairment of colour vision among workers exposed to styrene. Br J Ind Med. 1992 Oct;49(10):679–682. doi: 10.1136/oem.49.10.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Ferroni C., Selis L., Mutti A., Folli D., Bergamaschi E., Franchini I. Neurobehavioral and neuroendocrine effects of occupational exposure to perchloroethylene. Neurotoxicology. 1992 Spring;13(1):243–247. [PubMed] [Google Scholar]
  33. Fleishman J. A., Beck R. W., Linares O. A., Klein J. W. Deficits in visual function after resolution of optic neuritis. Ophthalmology. 1987 Aug;94(8):1029–1035. doi: 10.1016/s0161-6420(87)33349-4. [DOI] [PubMed] [Google Scholar]
  34. Frenette B., Mergler D., Bowler R. Contrast-sensitivity loss in a group of former microelectronics workers with normal visual acuity. Optom Vis Sci. 1991 Jul;68(7):556–560. doi: 10.1097/00006324-199107000-00009. [DOI] [PubMed] [Google Scholar]
  35. Garnier R., Bédouin J., Pépin G., Gaillard Y. Coin-operated dry cleaning machines may be responsible for acute tetrachloroethylene poisoning: report of 26 cases including one death. J Toxicol Clin Toxicol. 1996;34(2):191–197. doi: 10.3109/15563659609013769. [DOI] [PubMed] [Google Scholar]
  36. Gawande A. A., Donovan W. J., Ginsburg A. P., Marmor M. F. Photoaversion in retinitis pigmentosa. Br J Ophthalmol. 1989 Feb;73(2):115–120. doi: 10.1136/bjo.73.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Geller A. M., Hudnell H. K. Critical issues in the use and analysis of the Lanthony Desaturate Color Vision test. Neurotoxicol Teratol. 1997 Nov-Dec;19(6):455–465. doi: 10.1016/s0892-0362(97)00046-9. [DOI] [PubMed] [Google Scholar]
  38. Gilmore G. C., Levy J. A. Spatial contrast sensitivity in Alzheimer's disease: a comparison of two methods. Optom Vis Sci. 1991 Oct;68(10):790–794. doi: 10.1097/00006324-199110000-00006. [DOI] [PubMed] [Google Scholar]
  39. Gobba F., Galassi C., Imbriani M., Ghittori S., Candela S., Cavalleri A. Acquired dyschromatopsia among styrene-exposed workers. J Occup Med. 1991 Jul;33(7):761–765. [PubMed] [Google Scholar]
  40. Gobba F., Righi E., Fantuzzi G., Predieri G., Cavazzuti L., Aggazzotti G. Two-year evolution of perchloroethylene-induced color-vision loss. Arch Environ Health. 1998 May-Jun;53(3):196–198. doi: 10.1080/00039899809605695. [DOI] [PubMed] [Google Scholar]
  41. Greeves A. L., Cole B. L., Jacobs R. J. Assessment of contrast sensitivity of patients with macular disease using reduced contrast near visual acuity charts. Ophthalmic Physiol Opt. 1988;8(4):371–377. doi: 10.1111/j.1475-1313.1988.tb01171.x. [DOI] [PubMed] [Google Scholar]
  42. Hoshika Y., Imamura T., Muto G., Van Gemert L. J., Don J. A., Walpot J. I. International comparison of odor threshold values of several odorants in Japan and in The Netherlands. Environ Res. 1993 Apr;61(1):78–83. doi: 10.1006/enrs.1993.1051. [DOI] [PubMed] [Google Scholar]
  43. Hudnell H. K., Boyes W. K., Otto D. A., House D. E., Creason J. P., Geller A. M., Darcey D. J., Broadwell D. K. Battery of neurobehavioral tests recommended to ATSDR: solvent-induced deficits in microelectronic workers. Toxicol Ind Health. 1996 Mar-Apr;12(2):235–243. [PubMed] [Google Scholar]
  44. Hudnell H. K., Otto D. A., House D. E. The influence of vision on computerized neurobehavioral test scores: a proposal for improving test protocols. Neurotoxicol Teratol. 1996 Jul-Aug;18(4):391–400. doi: 10.1016/0892-0362(96)00040-2. [DOI] [PubMed] [Google Scholar]
  45. Hudnell H. K., Skalik I., Otto D., House D., Subrt P., Sram R. Visual contrast sensitivity deficits in Bohemian children. Neurotoxicology. 1996 Fall-Winter;17(3-4):615–628. [PubMed] [Google Scholar]
  46. Kulig B. M. The effects of chronic trichloroethylene exposure on neurobehavioral functioning in the rat. Neurotoxicol Teratol. 1987 Mar-Apr;9(2):171–178. doi: 10.1016/0892-0362(87)90095-x. [DOI] [PubMed] [Google Scholar]
  47. Kulig B. M. The neurobehavioral effects of chronic styrene exposure in the rat. Neurotoxicol Teratol. 1988 Nov-Dec;10(6):511–517. doi: 10.1016/0892-0362(88)90086-4. [DOI] [PubMed] [Google Scholar]
  48. Kupersmith M. J., Siegel I. M., Carr R. E. Subtle disturbances of vision with compressive lesions of the anterior visual pathway measured by contrast sensitivity. Ophthalmology. 1982 Jan;89(1):68–72. doi: 10.1016/s0161-6420(82)34864-2. [DOI] [PubMed] [Google Scholar]
  49. Lebel J., Mergler D., Lucotte M., Amorim M., Dolbec J., Miranda D., Arantès G., Rheault I., Pichet P. Evidence of early nervous system dysfunction in Amazonian populations exposed to low-levels of methylmercury. Neurotoxicology. 1996 Spring;17(1):157–167. [PubMed] [Google Scholar]
  50. Leguire L. E., Pappa K. S., Kachmer M. L., Rogers G. L., Bremer D. L. Loss of contrast sensitivity in cystic fibrosis. Am J Ophthalmol. 1991 Apr 15;111(4):427–429. doi: 10.1016/s0002-9394(14)72375-x. [DOI] [PubMed] [Google Scholar]
  51. Loshin D. S., White J. Contrast sensitivity. The visual rehabilitation of the patient with macular degeneration. Arch Ophthalmol. 1984 Sep;102(9):1303–1306. doi: 10.1001/archopht.1984.01040031053022. [DOI] [PubMed] [Google Scholar]
  52. Mergler D., Blain L. Assessing color vision loss among solvent-exposed workers. Am J Ind Med. 1987;12(2):195–203. doi: 10.1002/ajim.4700120208. [DOI] [PubMed] [Google Scholar]
  53. Mergler D., Blain L., Lagacé J. P. Solvent related colour vision loss: an indicator of neural damage? Int Arch Occup Environ Health. 1987;59(4):313–321. doi: 10.1007/BF00405275. [DOI] [PubMed] [Google Scholar]
  54. Mergler D., Blain L., Lemaire J., Lalande F. Colour vision impairment and alcohol consumption. Neurotoxicol Teratol. 1988 May-Jun;10(3):255–260. doi: 10.1016/0892-0362(88)90025-6. [DOI] [PubMed] [Google Scholar]
  55. Monster A. C., Boersma G., Steenweg H. Kinetics of tetrachloroethylene in volunteers; influence of exposure concentration and work load. Int Arch Occup Environ Health. 1979 Jan 15;42(3-4):303–309. doi: 10.1007/BF00377784. [DOI] [PubMed] [Google Scholar]
  56. Morkeberg J. C., Edmund C., Prause J. U., Lanng S., Koch C., Michaelsen K. F. Ocular findings in cystic fibrosis patients receiving vitamin A supplementation. Graefes Arch Clin Exp Ophthalmol. 1995 Nov;233(11):709–713. doi: 10.1007/BF00164674. [DOI] [PubMed] [Google Scholar]
  57. Mukuno K., Ishikawa S., Okamura R. Grating test of contrast sensitivity in patients with Minamata disease. Br J Ophthalmol. 1981 Apr;65(4):284–290. doi: 10.1136/bjo.65.4.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Muller K. E., Barton C. N., Benignus V. A. Recommendations for appropriate statistical practice in toxicologic experiments. Neurotoxicology. 1984 Summer;5(2):113–125. [PubMed] [Google Scholar]
  59. Onofrj M., Thomas A., Paci C., Rotilio D. Optic neuritis with residual tunnel vision in perchloroethylene toxicity. J Toxicol Clin Toxicol. 1998;36(6):603–607. doi: 10.3109/15563659809028057. [DOI] [PubMed] [Google Scholar]
  60. Ostergaard G., Lam H. R., Ladefoged O., Arlien-Søborg P. Effects of six months' white spirit inhalation exposure in adult and old rats. Pharmacol Toxicol. 1993 Jan;72(1):34–39. doi: 10.1111/j.1600-0773.1993.tb01336.x. [DOI] [PubMed] [Google Scholar]
  61. Quiceno J. I., Capparelli E., Sadun A. A., Munguia D., Grant I., Listhaus A., Crapotta J., Lambert B., Freeman W. R. Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 1992 Jan 15;113(1):8–13. doi: 10.1016/s0002-9394(14)75745-9. [DOI] [PubMed] [Google Scholar]
  62. Raitta C., Seppäläinen A. N., Huuskonen M. S. N-hexane maculopathy in industrial workers. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1978 Dec 15;209(2):99–110. doi: 10.1007/BF00407843. [DOI] [PubMed] [Google Scholar]
  63. Raitta C., Teir H., Tolonen M., Nurminen M., Helpiö E., Malmström S. Impaired color discrimination among viscose rayon workers exposed to carbon disulfide. J Occup Med. 1981 Mar;23(3):189–192. [PubMed] [Google Scholar]
  64. Regan D., Neima D. Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson's disease. Br J Ophthalmol. 1984 Dec;68(12):885–889. doi: 10.1136/bjo.68.12.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Román G. C. An epidemic in Cuba of optic neuropathy, sensorineural deafness, peripheral sensory neuropathy and dorsolateral myeloneuropathy. J Neurol Sci. 1994 Dec 1;127(1):11–28. doi: 10.1016/0022-510x(94)90130-9. [DOI] [PubMed] [Google Scholar]
  66. Ross J. E., Bron A. J., Reeves B. C., Emmerson P. G. Detection of optic nerve damage in ocular hypertension. Br J Ophthalmol. 1985 Dec;69(12):897–903. doi: 10.1136/bjo.69.12.897. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Sadun A. A., Borchert M., DeVita E., Hinton D. R., Bassi C. J. Assessment of visual impairment in patients with Alzheimer's disease. Am J Ophthalmol. 1987 Aug 15;104(2):113–120. doi: 10.1016/0002-9394(87)90001-8. [DOI] [PubMed] [Google Scholar]
  68. Sadun A. A., Martone J. F., Muci-Mendoza R., Reyes L., DuBois L., Silva J. C., Roman G., Caballero B. Epidemic optic neuropathy in Cuba. Eye findings. Arch Ophthalmol. 1994 May;112(5):691–699. doi: 10.1001/archopht.1994.01090170139037. [DOI] [PubMed] [Google Scholar]
  69. Sample P. A., Juang P. S., Weinreb R. N. Isolating the effects of primary open-angle glaucoma on the contrast sensitivity function. Am J Ophthalmol. 1991 Sep 15;112(3):308–316. doi: 10.1016/s0002-9394(14)76732-7. [DOI] [PubMed] [Google Scholar]
  70. Schreiber J. S., House S., Prohonic E., Smead G., Hudson C., Styk M., Lauber J. An investigation of indoor air contamination in residences above dry cleaners. Risk Anal. 1993 Jun;13(3):335–344. doi: 10.1111/j.1539-6924.1993.tb01085.x. [DOI] [PubMed] [Google Scholar]
  71. Seeber A. Neurobehavioral toxicity of long-term exposure to tetrachloroethylene. Neurotoxicol Teratol. 1989 Nov-Dec;11(6):579–583. doi: 10.1016/0892-0362(89)90041-x. [DOI] [PubMed] [Google Scholar]
  72. Seiple W. H., Holopigian K., Greenstein V. C., Hood D. C. Sites of cone system sensitivity loss in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1993 Aug;34(9):2638–2645. [PubMed] [Google Scholar]
  73. Shoemaker R. C., Hudnell H. K. Possible estuary-associated syndrome: symptoms, vision, and treatment. Environ Health Perspect. 2001 May;109(5):539–545. doi: 10.1289/ehp.01109539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Shoemaker R. C. Residential and recreational acquisition of possible estuary-associated syndrome: a new approach to successful diagnosis and treatment. Environ Health Perspect. 2001 Oct;109 (Suppl 5):791–796. doi: 10.1289/ehp.01109s5791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Sokol S., Moskowitz A., Skarf B., Evans R., Molitch M., Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985 Jan;103(1):51–54. doi: 10.1001/archopht.1985.01050010055018. [DOI] [PubMed] [Google Scholar]
  76. Stein V. B., Narang R. S., Wilson L., Aldous K. M. A simple, reliable method for the determination of chlorinated volatile organics in human breath and air using glass sampling tubes. J Anal Toxicol. 1996 May-Jun;20(3):145–150. doi: 10.1093/jat/20.3.145. [DOI] [PubMed] [Google Scholar]
  77. Stein V. B., Narang R. S., Wilson L., Aldous K. M. A simple, reliable method for the determination of chlorinated volatile organics in human breath and air using glass sampling tubes. J Anal Toxicol. 1996 May-Jun;20(3):145–150. doi: 10.1093/jat/20.3.145. [DOI] [PubMed] [Google Scholar]
  78. Trick G. L., Burde R. M., Gordon M. O., Santiago J. V., Kilo C. The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology. 1988 May;95(5):693–698. doi: 10.1016/s0161-6420(88)33125-8. [DOI] [PubMed] [Google Scholar]
  79. Zavalić M., Mandić Z., Turk R., Bogadi-Sare A., Plavec D. Quantitative assessment of color vision impairment in workers exposed to toluene. Am J Ind Med. 1998 Mar;33(3):297–304. doi: 10.1002/(sici)1097-0274(199803)33:3<297::aid-ajim12>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES